Frega S - Search Results

1

Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?

Frega S, Bonanno L, Guarneri V, Conte P, Pasello G. Frega S, et al. Crit Rev Oncol Hematol. 2018 Aug;128:19-29. doi: 10.1016/j.critrevonc.2018.05.013. Epub 2018 May 24. Crit Rev Oncol Hematol. 2018. PMID: 29958628 Review.

2

Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature.

Polo V, Zago G, Frega S, Canova F, Bonanno L, Favaretto A, Bonaldi L, Bertorelle R, Conte P, Pasello G. Polo V, et al. Among authors: frega s. Am J Case Rep. 2015 Nov 3;16:782-9. doi: 10.12659/ajcr.894426. Am J Case Rep. 2015. PMID: 26525068 Free PMC article. Review.

3

Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization.

Polo V, Pasello G, Frega S, Favaretto A, Koussis H, Conte P, Bonanno L. Polo V, et al. Among authors: frega s. Oncotarget. 2016 May 3;7(18):25050-63. doi: 10.18632/oncotarget.7732. Oncotarget. 2016. PMID: 26933818 Free PMC article. Review.

4

A Triple Rare E709K and L833V/H835L EGFR Mutation Responsive to an Irreversible Pan-HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with Afatinib.

Frega S, Conte P, Fassan M, Polo V, Pasello G. Frega S, et al. J Thorac Oncol. 2016 May;11(5):e63-e64. doi: 10.1016/j.jtho.2016.01.023. J Thorac Oncol. 2016. PMID: 27131295 Free article. No abstract available.

5

Immunotherapy-related skin toxicity: bullous pemphigoid in a lung adenocarcinoma patient treated with the anti-PDL1 antibody atezolizumab.

Russo I, Sacco G, Frega S, Polo V, Pasello G, Alaibac M. Russo I, et al. Among authors: frega s. Eur J Dermatol. 2017 Apr 1;27(2):205-208. doi: 10.1684/ejd.2016.2959. Eur J Dermatol. 2017. PMID: 28251900 Review. No abstract available.

6

Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations.

Frega S, Lorenzi M, Fassan M, Indraccolo S, Calabrese F, Favaretto A, Bonanno L, Polo V, Zago G, Lunardi F, Attili I, Pavan A, Rugge M, Guarneri V, Conte P, Pasello G. Frega S, et al. Oncotarget. 2017 May 16;8(20):32626-32638. doi: 10.18632/oncotarget.15945. Oncotarget. 2017. PMID: 28427238 Free PMC article.

7

From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study).

Pasello G, Vicario G, Zustovich F, Oniga F, Gori S, Rosetti F, Bonetti A, Favaretto A, Toso S, Redelotti R, Santo A, Bernardi D, Giovanis P, Oliani C, Calvetti L, Gatti C, Palazzolo G, Baretta Z, Bortolami A, Bonanno L, Basso M, Menis J, Corte DD, Frega S, Guarneri V, Conte P; Veneto Oncology Network. Pasello G, et al. Among authors: frega s. Oncologist. 2019 Jun;24(6):e318-e326. doi: 10.1634/theoncologist.2018-0712. Epub 2019 Mar 7. Oncologist. 2019. PMID: 30846513 Free PMC article.

8

18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy.

Evangelista L, Cuppari L, Menis J, Bonanno L, Reccia P, Frega S, Pasello G. Evangelista L, et al. Among authors: frega s. Nucl Med Commun. 2019 Aug;40(8):802-807. doi: 10.1097/MNM.0000000000001025. Nucl Med Commun. 2019. PMID: 31045745

9

Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?

Frega S, Dal Maso A, Ferro A, Bonanno L, Conte P, Pasello G. Frega S, et al. Crit Rev Oncol Hematol. 2019 Jun;138:87-103. doi: 10.1016/j.critrevonc.2019.03.012. Epub 2019 Apr 6. Crit Rev Oncol Hematol. 2019. PMID: 31092389 Review.

10

Corrigendum to "Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?" [Crit. Rev. Oncol. Hematol. 138 (June) (2019), 87-103].

Frega S, Dal Maso A, Ferro A, Bonanno L, Conte PF, Pasello G. Frega S, et al. Crit Rev Oncol Hematol. 2019 Aug;140:73. doi: 10.1016/j.critrevonc.2019.05.018. Epub 2019 Jun 6. Crit Rev Oncol Hematol. 2019. PMID: 31176852 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page